Downloads

  1. Modernizing CSV: How AI And CSA Are Changing The Game 9/9/2025

    Explore how life sciences companies are streamlining validation with AI and CSA principles. Learn practical strategies that boost efficiency, accuracy, and compliance—backed by real-world examples.

  2. Validation In Transition: 2025's Top Trends, Tools, And Takeaways 9/9/2025

    Join top validation experts for a dynamic panel discussion on the 2025 State of Validation Report—uncovering key trends, challenges, and innovations shaping pharmaceutical validation practices today.

  3. The Cost Of Delaying Digital Validation 9/9/2025

    Digital validation is reshaping quality assurance to offer speed, scalability, and strategic advantage. Discover how digital tools can elevate your QA approach.

  4. Ethylene Oxide For Industrial Sterilization: Part 2 9/9/2025

    Sterilization process development ensures product safety and compliance through optimized cycles. Learn how biological indicators and process challenge devices strengthen your sterilization strategy.

  5. Ethylene Oxide For Industrial Sterilization: Part 1 9/9/2025

    Understanding EO sterilization requires careful control of cycle variables and strict safety protocols. Learn how evolving standards and best practices ensure both effective sterilization and compliance.

  6. Validation Of A Sterilization Process: Part 3 9/9/2025

    Explore the full scope of sterilization activities and gain key insights into cycle development and validation using BI and BB methods to ensure product sterility and regulatory compliance.

  7. Validation Of A Sterilization Process: Part 2 9/9/2025

    Gain essential insights into sterilization processes by exploring the Overkill method—an approach that ensures product safety through rigorous cycle development and validation.

  8. Validation Of A Sterilization Process: Part 1 9/9/2025

    Gain essential insights into sterilization by exploring microbial inactivation kinetics, bacterial spore resistance, and key terminology—critical knowledge for ensuring product safety and compliance.

  9. Development Of A Non-Standard Protein Therapeutic 9/9/2025

    Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.

  10. The New FDA Era Of Radical Transparency And Pervasive Oversight 9/9/2025

    The first half of 2025 has been transformative for biopharmaceutical quality and regulatory affairs, with the FDA leading the charge with four significant changes. Curadian Group's David Grote discusses implications for all four.